Boston Scientific Corp. (BSX) Stock Price

BSXStockS&P 500

$44.39−54.60%52W

Market Cap$64.33B

P/E22.20x

PEG Ratio0.62

Div yield—

Beta0.59

BSX Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-40.35%

Price vs S&P 500 (4W)2.86%

PEG Ratio0.62

VGM Score58.38

P/E Ratio (Annual)22.20x

P/CF (Annual)14.19x

Book Value / Share (Quarterly)$17.23

P/TBV (Annual)8.21x

Revenue Growth (3Y)16.54%

Cash Flow / Share (Quarterly)$2.51

Price vs S&P 500 (YTD)-65.37%

Gross Margin (TTM)69.50%

Net Profit Margin (TTM)17.50%

EPS (TTM)$2.47

10-Day Avg Trading Volume14.94M

EPS Excl Extra (TTM)$2.47

Revenue Growth (5Y)15.16%

EPS (Annual)$1.94

Dividend / Share (Annual)$0.00

ROI (Annual)8.12%

Gross Margin (Annual)69.01%

Net Profit Margin (5Y Avg)10.19%

Cash / Share (Quarterly)$0.37

P/E Basic Excl Extra (TTM)17.51x

Revenue Growth QoQ (YoY)7.53%

P/E Normalized (Annual)22.20x

ROA (Last FY)6.64%

Revenue Growth TTM (YoY)13.53%

EBITD / Share (TTM)$3.40

ROE (5Y Avg)7.79%

Operating Margin (TTM)19.78%

Cash Flow / Share (Annual)$2.47

P/B Ratio2.58x

P/B Ratio (Quarterly)2.54x

Net Income / Employee (Annual)$49,100

EV / Revenue (TTM)3.64x

Net Interest Coverage (TTM)18.54x

ROA (TTM)8.35%

EPS Growth QoQ (YoY)15.25%

EV / EBITDA (TTM)15.07x

EPS Incl Extra (Annual)$1.94

Current Ratio (Annual)1.62x

Quick Ratio (Quarterly)0.68x

3-Month Avg Trading Volume19.70M

52-Week Price Return-54.60%

EV / Free Cash Flow (Annual)20.89x

P/E Incl Extra (TTM)17.51x

Revenue / Employee (TTM)$355,900

Tangible BV / Share (Quarterly)$12.45

P/S Ratio (Annual)3.20x

Asset Turnover (Annual)0.46x

52-Week High$105.65

Operating Margin (5Y Avg)14.58%

EPS Excl Extra (Annual)$1.94

CapEx CAGR (5Y)10.91%

Tangible BV CAGR (5Y)12.84%

26-Week Price Return-30.45%

Quick Ratio (Annual)1.02x

13-Week Price Return0.82%

Total Debt / Equity (Annual)0.47x

Current Ratio (Quarterly)1.24x

Enterprise Value$76.42B

Revenue / Share Growth (5Y)13.93%

Asset Turnover (TTM)0.48x

Book Value / Share Growth (5Y)8.60%

Revenue / Employee (Annual)$340,200

Inventory Turnover (Annual)2.16x

Pretax Margin (Annual)16.86%

Cash / Share (Annual)$1.32

3-Month Return Std Dev33.20%

Gross Margin (5Y Avg)69.08%

Net Income / Employee (TTM)$62,300

EBITDA CAGR (5Y)44.78%

EBITDA Interim CAGR (5Y)26.13%

ROE (Last FY)11.96%

Net Interest Coverage (Annual)10.63x

EPS Basic Excl Extra (Annual)$1.94

P/FCF (TTM)17.75x

Receivables Turnover (TTM)7.16x

EV / Free Cash Flow (TTM)21.08x

Total Debt / Equity (Quarterly)0.51x

EPS Incl Extra (TTM)$2.47

Receivables Turnover (Annual)7.32x

ROI (TTM)10.13%

P/S Ratio (TTM)3.06x

Pretax Margin (5Y Avg)12.50%

Revenue / Share (Annual)$13.43

Tangible BV / Share (Annual)$11.61

Forward P/E13.67x

Free OCF CAGR (5Y)29.98%

Price vs S&P 500 (52W)-70.13%

P/E Ratio (TTM)17.51x

EPS Growth TTM (YoY)46.78%

Year-to-Date Return-53.45%

5-Day Price Return1.25%

EPS Normalized (Annual)$1.94

ROA (5Y Avg)4.25%

Net Profit Margin (Annual)14.44%

Month-to-Date Return1.70%

Cash Flow / Share (TTM)$1.63

EBITD / Share (Annual)$3.02

EPS Growth (3Y)58.74%

Operating Margin (Annual)18.00%

LT Debt / Equity (Annual)0.46x

P/CF (TTM)14.20x

ROI (5Y Avg)5.22%

P/E Excl Extra (TTM)17.51x

LT Debt / Equity (Quarterly)0.44x

EPS Basic Excl Extra (TTM)$2.47

P/TBV (Quarterly)3.52x

P/B Ratio (Annual)5.83x

Dividend / Share (TTM)$0.00

Inventory Turnover (TTM)2.10x

Pretax Margin (TTM)18.39%

Book Value / Share (Annual)$16.34

Price vs S&P 500 (13W)-1.87%

Dividend Yield (TTM)0.00%

Beta0.59x

P/FCF (Annual)17.59x

Revenue / Share (TTM)$14.24

ROE (TTM)14.94%

52-Week Low$41.38

vGradeC

gGradeB

mGradeC

vgmGradeC

BSX Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Jul 29, 2026	$0.83	$0.86	+3.86%(+$0.03)
Q1 2026	Apr 22, 2026	$0.79	$0.80	+1.62%(+$0.01)
Q4 2025	Feb 4, 2026	$0.78	$0.80	+2.43%(+$0.02)
Q3 2025	Oct 22, 2025	$0.71	$0.75	+5.09%(+$0.04)
Q2 2025	Jul 23, 2025	$0.73	$0.75	+3.42%(+$0.02)

BSX Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.10

4.08

Industry Peers — Surgical & Medical Instruments(142)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
BSXBoston Scientific Corp.	C	B	C	3.1x	15.2%	69.5%	19.8%	$44.39
SYKStryker Corporation	C	B	C	4.4x	11.8%	65.3%	21.3%	$294.66
MMM3M Company	C	D	B	3.4x	-5.0%	39.4%	18.4%	$164.75
BDXBecton, Dickinson and Co.	B	D	A	2.5x	6.3%	46.7%	9.6%	$191.75
MDLNMedline Inc. Class A common stock	C	D	C	1.6x	—	26.2%	6.0%	$35.96
RMDResMed Inc.	C	C	B	5.9x	12.1%	61.1%	33.4%	$238.97
DXCMDexCom, Inc.	C	B	B	6.5x	19.3%	64.3%	22.9%	$86.04
WSTWest Pharmaceutical Services, Inc.	D	C	A	8.5x	7.4%	36.8%	20.4%	$384.02
SOLVSolventum Corporation	C	C	B	1.8x	—	54.8%	23.9%	$85.81
BAXBaxter International Inc.	B	D	B	1.1x	-0.8%	30.7%	-2.3%	$25.28
PENPenumbra, Inc.	F	C	B	8.4x	20.2%	67.8%	12.4%	$320.86
GMEDGLOBUS MEDICAL INC	B	B	B	3.3x	30.1%	68.5%	20.6%	$76.71
PODDInsulet Corporation	C	A	C	3.2x	24.5%	71.1%	16.9%	$141.10
GKOSGlaukos Corporation	F	A	B	15.9x	17.7%	79.1%	-31.6%	$164.84
TFXTeleflex Incorporated	B	F	B	2.1x	-4.7%	53.8%	-11.7%	$130.43
HAEHaemonetics Corporation	C	C	A	4.0x	8.9%	59.1%	11.9%	$118.28
MMSIMerit Medical Systems Inc	C	B	B	3.4x	9.5%	49.5%	12.8%	$89.20
STVNStevanato Group S.p.A.	D	C	C	3.7x	12.4%	29.9%	16.4%	$18.90
MMEDMiniMed Group, Inc. Common Stock	—	—	B	—	—	—	—	$17.49
HTFLHeartflow, Inc. Common Stock	F	A	A	19.8x	—	80.1%	-40.8%	$48.29
ICUIICU Medical Inc	C	D	B	1.9x	11.9%	39.1%	3.5%	$162.99
IRTCiRhythm Holdings, Inc. Common Stock	D	B	C	4.3x	23.0%	71.5%	-3.0%	$108.66
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	2725.9x	—	0.3%	-7007.8%	$44.43
ATRCAtriCure, Inc.	D	B	A	5.0x	20.9%	76.3%	2.3%	$56.07
UFPTUFP Technologies Inc	C	B	A	3.6x	27.4%	28.5%	15.3%	$291.67
INSPInspire Medical Systems, Inc.	B	B	B	2.2x	51.2%	86.1%	6.0%	$68.79
LMATLeMaitre Vascular, Inc.	C	B	C	7.0x	14.0%	72.9%	29.5%	$80.82
NVCRNovoCure Limited Ordinary Shares	D	C	C	2.3x	5.8%	76.1%	-22.1%	$14.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	15.2x	—	53.9%	-140.4%	$27.24
ATECAlphatec Holdings, Inc.	D	B	C	2.0x	39.5%	70.8%	-7.5%	$10.46
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	B	—	—	—	—	$12.29
TNDMTandem Diabetes Care, Inc.	D	C	C	1.1x	15.3%	56.0%	-4.4%	$16.24
IRMDiRadimed Corporation	D	B	B	13.1x	21.4%	75.9%	31.9%	$88.27
AORTArtivion, Inc.	C	C	C	2.3x	11.8%	64.4%	2.9%	$21.78
IARTIntegra LifeSciences Holdings	B	F	C	0.6x	3.6%	57.2%	4.0%	$13.21
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	3.0x	109.0%	64.2%	-33.9%	$17.57
BVSBioventus Inc. Class A Common Stock	B	C	A	1.9x	12.1%	68.7%	10.0%	$13.30
BBNXBeta Bionics, Inc. Common Stock	D	A	C	7.4x	—	58.3%	-69.8%	$16.35
SIBNSI-BONE, Inc. Common Stock	D	B	B	4.1x	22.3%	79.5%	-8.3%	$19.68
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	—	—	—	—	$24.00
MDXGMiMedx Group, Inc	C	D	C	1.8x	11.0%	78.8%	2.5%	$4.43
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	2.3x	27.2%	73.7%	-11.9%	$21.95
TCMDTactile Systems Technology, Inc.	B	B	B	1.5x	12.0%	51.9%	10.0%	$22.52
SSIISS Innovations International Inc. Common Stock	F	A	D	9.7x	—	47.6%	-16.2%	$2.53
DCTHDelcath Systems Inc	D	C	B	5.1x	120.1%	87.0%	-1.9%	$14.08
ANGOAngioDynamics, Inc.	C	D	C	1.5x	1.9%	55.6%	-11.2%	$11.24
BWAYBrainsway Ltd. American Depositary Shares	D	B	B	9.5x	12.2%	74.9%	5.8%	$11.44
SGHTSight Sciences, Inc. Common Stock	D	B	A	5.5x	22.9%	88.4%	-33.4%	$8.28
CERSCerus Corp	D	C	C	1.8x	15.4%	57.2%	-0.7%	$2.18
NPCENeuropace, Inc. Common Stock	D	C	C	4.3x	19.4%	79.6%	-15.3%	$12.24
RCELAvita Medical, Inc. Common Stock	D	C	A	5.3x	19.6%	82.1%	-46.6%	$13.04

About Boston Scientific Corp.

Boston Scientific manufactures minimally invasive medical devices for interventional procedures across cardiac rhythm management, interventional oncology, neuromodulation, and diagnostic imaging applications. The company serves healthcare institutions globally, with approximately 36% of revenues generated internationally.

BSX Next Earnings Report

Report dateOct 28, 2026

QuarterQ3 2026

Report timeBMO

EPS estimate$0.74

Revenue estimate$5.09B

Also reporting on Oct 28, 2026

Scheduled date with consensus estimates — both can change before the company reports.

Earnings calendar for October 2026

BSX Insider Transactions

BuyAug 25, 2026
MORANO SUSAN E.
Director
Shares: 2,040Value: $100,408
BuyAug 5, 2026
HABIGER DAVID C
Director
Shares: 2,100Value: $99,937
BuyAug 4, 2026
HABIGER DAVID C
Director
Shares: 1,182Value: $56,887
BuyAug 3, 2026
MAHONEY MICHAEL F
Chief Executive Officer
Shares: 186,240Value: $9.00M
BuyJul 31, 2026
LUDWIG EDWARD J.
Director
Shares: 5,000Value: $227,400

Open-market buys and sells filed with the SEC over the last 90 days. Grants, gifts and option exercises are excluded.

All insider transactions for August 2026

Companies in Related Industries

ISRGIntuitive Surgical Inc.Orthopedic & Prosthetic Devices
MDTMedtronic plcElectromedical Equipment
TTTrane Technologies plc
NOCNorthrop Grumman Corp.Defense Systems & Equipment
AMEAmetek, Inc.Industrial Instruments
KEYSKeysight Technologies, Inc.Industrial Instruments
GRMNGarmin LtdDefense Systems & Equipment
TERTeradyne, Inc. Common StockInstruments for Measuring

Same SIC sector, outside this company's own industry.

Analyst Sentiment

4.1

Buy

Consensus rating

52-Week Range

Low$41.38

High$105.65